CDK2-IN-73 : Use of cyclin‑dependent kinase (CDK) 4/6 inhibitors for hormone receptor‑positive, human epidermal growth factor receptor 2‑negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)
GDC-0980 : Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells